EUVIMEDEUVIMED entdecken
Open Access

High Bacillary Burden and the ESX-1 Type VII Secretion System Promote MHC Class I Presentation by Mycobacterium tuberculosis –Infected Macrophages to CD8 T Cells

Daniel Mott iD, Jason Yang iD, Christina Baer iD, Kadamba Papavinasasundaram iD, Christopher M Sassetti, Samuel M Behar iD

The Journal of Immunology · 2023

DOI: 10.4049/jimmunol.2300001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Daniel Mott und 5 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Microbiology Program, Graduate School of Biomedical Science, Worcester, MA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Type VII Secretion Systems, Bacillus, Tuberculosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We used a mouse model to study how Mycobacterium tuberculosis subverts host defenses to persist in macrophages despite immune pressure. CD4 T cells can recognize macrophages infected with a single bacillus in vitro. Under identical conditions, CD8 T cells inefficiently recognize infected macrophages and fail to restrict M. tuberculosis growth, although they can inhibit M. tuberculosis growth during high-burden intracellular infection. We show that high intracellular M. tuberculosis numbers cause macrophage death, leading other macrophages to scavenge cellular debris and cross-present the TB10.4 Ag to CD8 T cells. Presentation by infected macrophages requires M. tuberculosis to have a functional ESX-1 type VII secretion system. These data indicate that phagosomal membrane damage and cell death promote MHC class I presentation of the immunodominant Ag TB10.4 by macrophages. Although this mode of Ag presentation stimulates cytokine production that we presume would be host beneficial, killing of uninfected cells could worsen immunopathology. We suggest that shifting the focus of CD8 T cell recognition to uninfected macrophages would limit the interaction of CD8 T cells with infected macrophages and impair CD8 T cell–mediated resolution of tuberculosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisType VII Secretion SystemsBacillusTuberculosisMiceAnimalsAntigens, BacterialCD8-Positive T-LymphocytesMacrophages

Substanzen

Type VII Secretion SystemsAntigens, Bacterial

Autor:innen und Institutionen

  • Immunology and Microbiology Program, Graduate School of Biomedical Science, Worcester, MA.
  • Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA.

ORCID-Profile: Daniel Mott, Jason Yang, Christina Baer, Kadamba Papavinasasundaram, Samuel M Behar

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Mott, D., Yang, J., Baer, C., Papavinasasundaram, K., Sassetti, C. M., & Behar, S. M. (2023). High Bacillary Burden and the ESX-1 Type VII Secretion System Promote MHC Class I Presentation by Mycobacterium tuberculosis –Infected Macrophages to CD8 T Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300001

Vancouver

Mott D, Yang J, Baer C, Papavinasasundaram K, Sassetti CM, Behar SM. High Bacillary Burden and the ESX-1 Type VII Secretion System Promote MHC Class I Presentation by Mycobacterium tuberculosis –Infected Macrophages to CD8 T Cells. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2300001

BibTeX
@article{Mott2023,
  author = {Mott, Daniel and Yang, Jason and Baer, Christina and Papavinasasundaram, Kadamba and Sassetti, Christopher M and Behar, Samuel M},
  title = {High Bacillary Burden and the ESX-1 Type VII Secretion System Promote MHC Class I Presentation by Mycobacterium tuberculosis –Infected Macrophages to CD8 T Cells},
  journal = {The Journal of Immunology},
  year = {2023},
  doi = {10.4049/jimmunol.2300001}
}
Kostenlos starten →